Robert W. Duggan - Jun 14, 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director, 10%+ Owner
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Stock symbol
PLSE
Transactions as of
Jun 14, 2023
Transactions value $
$11,816,585
Form type
4
Date filed
6/16/2023, 04:12 PM
Previous filing
Jun 6, 2023
Next filing
Jul 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Exercise of in-the-money or at-the-money derivative security $11.7M +5.68M +18.69% $2.05 36.1M Jun 14, 2023 Direct
transaction PLSE Common Stock Exercise of in-the-money or at-the-money derivative security $166K +81K +19.71% $2.05 492K Jun 14, 2023 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Warrant (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -5.68M -100% $0.00* 0 Jun 14, 2023 Common Stock 5.68M $2.05 Direct
transaction PLSE Warrant (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -81K -100% $0.00* 0 Jun 14, 2023 Common Stock 81K $2.05 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.